Abstract
We have demonstrated bovine or human lactoferrin to be an anabolic factor in skeletal tissue. In vitro, lactoferrin stimulates the proliferation of bone forming cells, osteoblasts, and cartilage cells at physiological concentrations (above 0.1 μg/ml). The magnitude of this effect exceeds that observed in response to other skeletal growth factors such as IGF-1 and TGFβ. DNA synthesis is also stimulated in a bone organ culture system likely reflecting the proliferation of cells of the osteoblast lineage. Lactoferrin is also a potent osteoblast survival factor. In TUNEL and DNA fragmentation assays, lactoferrin decreased apoptosis, induced by serum withdrawal, by up to 70%. In addition, lactoferrin has powerful effects on bone resorbing cells, osteoclasts, decreasing osteoclast development at concentrations >1 μg/ml in a murine bone marrow culture system. However, lactoferrin did not alter bone resorption in calvarial organ culture, suggesting that it does not influence mature osteoclast function. In vivo, local injection of lactoferrin in adult mice resulted in increased calvarial bone growth, with significant increases in bone area and dynamic histomorphometric indices of bone formation after only 5 injections. Taken together, these data demonstrate that the naturally-occurring glycoprotein lactoferrin is anabolic to bone in vivo, an effect which is consequent upon its potent proliferative and anti-apoptotic actions in osteoblasts, and its ability to inhibit osteoclastogenesis. Lactoferrin may therefore have a physiological role in bone growth, and a potential therapeutic role in osteoporosis.
Similar content being viewed by others
References
Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJS, Reid IR. 2001 Effects of calcitonin, amylin and calcitonin gene-related peptide on osteoclast development. Bone 29, 162-168.
Cornish J, Callon KE, Gasser JA et al. 2000 Systemic administration of a novel octapeptide, amylin-(1-8), increases bone volume in male mice. Am J Physiol 279, E730-E735.
Cornish J, Callon KE, Lin CQ-X et al. 1999 Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol 277 E779-E785.
Grey A, Chen Q, Callon K, Xu X, Reid IR, Cornish J. 2002 The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving Gi proteins and PI-3 kinase. Endocrinol 143, 4755-4763.
Lönnerdal B, Iyer S. 1995 Lactoferrin: molecular structure and biological function. Ann Rev Nutrition 15, 93-110.
Lorget F, Clough J, Oliveira M, Daury MC, Sabokbar A, Offord E. 2002 Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 296, 261-266.
Mundy GR. 1999a Bone Remodeling. In Favus MJ (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Fourth Edition. Philadelphia, Lippincott Williams &; Wilkins, pp 30-38.
Mundy G, Garrett R, Harris S et al. 1999b Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946-1949.
Robey PG, Termine JD 1985 Human bone cells in vitro. Calcified Tissue Int 37, 453-460.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cornish, J. Lactoferrin promotes bone growth. Biometals 17, 331–335 (2004). https://doi.org/10.1023/B:BIOM.0000027713.18694.91
Issue Date:
DOI: https://doi.org/10.1023/B:BIOM.0000027713.18694.91